Profits from Drugs

">Managed Care’s

">Pharmaceutical

Attracting the Media Glare

Art Smarts

">Acing the Angel

Trading Up

Searching Polish

Long Line Learning

Corrections or additions?

This stories by Peter J. Mladineo and Barbara Fox were published in

U.S. 1 Newspaper on March 25, 1998. All rights reserved.

Survival Guide

Top Of Page
Profits from Drugs

New Jersey firms have developed one-third (an average

of 31 percent) of all drugs approved by the Food and Drug Administration

since 1992, and in 1996, 28 percent of the FDA-approved new molecular

entities came from New Jersey companies. These figures come from a

Coopers & Lybrand study of 13 companies sponsored by a relatively

new consortium, the Healthcare Institute of New Jersey. Including

all the services provided to these firms, the economic impact was

about $8 billion in 1996.

Established last year, the institute costs $50,000 a year to join

and is limited to firms with at least a billion dollars in sales.

"Our major aim is to raise the awareness, understanding, and public

support for what the research and pharmaceutical companies do in New

Jersey," says William Tremayne, the institute’s president.

His institute members are among the chief providers of capital for

the smaller firms. Princeton area members include American Home Products

(owners of American Cyanamid on Quakerbridge Road), Bracco Diagnostics

on College Road East, Nycomed Amersham at the Carnegie Center, Bristol-Myers

Squibb, and Johnson & Johnson. Other members of the institute, based

at 100 Albany Street in New Brunswick, are Hoffman-LaRoche, Hoechst

Marion Roussel, Merck, Novartis, Schering-Plough, Knoll, Warner-Lambert,

Becton Dickinson, and Pfizer (Howmedica Inc.)

These members have 11 locations in Mercer County, 20 in Middlesex

County, and 21 in Somerset. Together, says Coopers & Lybrand, these

firms employed more than 53,000 workers in New Jersey in 1996, and

82 percent of them were state residents. With a total payroll of $3.2

billion, the average salary was $58,380 in 1996, and the total benefits

for both active and retired employees amounted to $610 million. They

contracted for more than $500 million in services and paid $220 million

to state-based vendors and suppliers of sales and marketing services.

(U.S. 1 statistics agree. Eight of the 25 largest firms in the U.S.

1 Business Directory are pharmaceutical or biotech related and they

comprise more than 16,000 workers, and more than 800 people are employed

in companies that service the drug industry.)

For more facts that buttress New Jersey’s reputation as a pharmaceutical

center call William R. Healey at the Healthcare Institute at

732-342-8442; fax, 732-342-8449.

Many of the smaller bio-tech companies are represented by the Biotechnology

Council of New Jersey, which charges from $500 to $3,500, depending

on company size. Call Debbie Hart, executive director (609-890-3185;

fax 609-581-8244) for details on the BCNJ, which calls this state

"the medicine chest of the world."

It has its own report, "Bio-New Jersey ’97: Riding the Rollercoaster,"

presented by Gordon Ramseier of the Sage Group and Robert

Esposito of KPMB Peat Marwick, with details on how the New Jersey

biotech index outperformed the national average.

The BCNJ offers such options as a purchasing consortium (group discounts

from BioPurchasing and Fisher Scientific) and forums for the exchange

of information. Donald Drakeman of Medarex is the chair, Elizabeth

E. Tallett the treasurer, and the board members include Joseph

Mollica of Pharmacopeia and Thomas McKearn of Cytogen (both

on College Road), Ronald Pepin of Bristol-Myers Squibb on Route

206, and Burt Ensley of Phytotech at Princeton Corporate Plaza.

Though the name says "biotech" pharmaceutical firms may join

as allied members, and they get a vote.

But you do not need to be a research-based company to be an associate

member of BCNJ, and at the most recent "Breakfast with Bio,"

more than half of those present represented service industries (real

estate, engineering, chemical suppliers, recruiters, stock brokers,

public relations services, and attorneys) rather than executives from

the pharmaceutical companies themselves. Billings from professionals

like these make up a substantial part of that $8 billion impact.

Barbara Fox

Top Of Page
Managed Care’s

Implications

Feelings about managed care depend upon the eye of the

beholder. Patients distrust it, health insurers insist on it, and

for doctors, it’s either gold or kryptonite, depending on the perspective.

Vince Maressa, who has presided over the Medical Society of

New Jersey as executive director and general counsel since 1973, says

that the impact of managed care has hugely impacted doctors —

for better or worse. Maressa is a panelist at a conference at Rider

University, "The Changing Structure of the Health Marketplace:

Implications for the Management and Delivery of Care," on Friday,

March 27, at 8:30 a.m. at Sweigart Hall. Call 609-895-5515.

"We’ve gone from a system where it was 90 percent indemnity insurance,"

says Maressa. "When you combine the HMOs and the indemnity companies

using managed care, there’s only about 10 percent that is not under

some sort of managed care program. This has produced dramatic and

significant effects on how care is managed and delivered."

This has created a sort of Darwinistic survival scheme for physicians.

"Some people are adapting very well and others can not adapt,"

he says. "In my 30 years in the industry, this is probably the

first time that a physician faces a real potential of going out of

business."

This is happening for two reasons, Maressa says. Number one, if a

doctor is not lucky enough to become a contracted provider in a managed

care network, the doctor may have a hard time finding customers. Number

two, the number of physicians has increased significantly while the

general population hasn’t. "When I first came to the Medical Society,

they used to talk about the physicians nationwide numbering roughly

300,000," he says. "In New Jersey at that time there were

about 12,000. Now there are in excess of 25,000. The number of physicians

has doubled, the number of people in New Jersey has not doubled in

that timeframe."

But like most oversaturated industries, the oversaturation is concentrated

in affluent regions, explains Maressa, 55, who has a law degree from

Temple University (Class of 1967) and started working for the 231-year-old

Medical Society of New Jersey immediately afterward. "There are

plenty of doctors around," he adds. "They may not be in some

of the right places. I’m sure there are people in inner cities in

New Jersey who may be have trouble finding a physician."

But as the number of physicians grows, the number of health insurers

is dwindling. "There used to be at one time the better part of

300 or 400 companies writing health insurances in New Jersey,"

Maressa reports. "I doubt today there are more than 50 to 100

of those companies. The paying side has shrunk down considerably but

each payer is larger and more aggressive than it used to be, and each

of them tries to leverage the provider end of the business."

Consolidations are rippling through related industries as well. The

Medical Society’s affiliate, the Medical Inter-Insurance Exchange

of New Jersey, which provides casualty malpractice insurance for physicians,

recently made news when it started making preparations to go public.

This comes after more than 20 years of being underwritten by mutual

funds, and represents a trend being experienced by nearly all of its

competitors. "The nature of the business is they have to expand

their writing both by geography and by type," says Maressa. "So

they have to raise capital. In this country there are 40 to 45 casualty

companies started by doctors to provide malpractice insurance and

many of them have converted into stock companies (from mutual funds)

because of the demands to raise capital."

The March 27 panel includes John Gantner, treasurer of Robert

Wood Johnson University Hospital; Susan Reinhard, deputy commissioner

of the New Jersey Department of Health; Mike Doodson, vice president

of customer service for Merck & Company; Bryan Markowitz, director

of health affairs for the New Jersey Business and Industry Association;

and Amy Mansue, vice president of administration for HIP Health

Plan of New Jersey. The moderator is Hope Corman, an economics

professor at Rider University. Afterward there will be several workshops

held by other Rider faculty.

"One of the trends we’re going to address directly is the consolidation

and integration that’s occurring in the healthcare industry,"

says Anne Carroll, an associate professor of finance at Rider,

who organized the event and will present one of the workshops. "Doctors

want to unionize, hospitals are merging, doctors are merging together

to form bigger groups to better negotiate with managed care plans.

And managed care plans themselves are merging to get more market clout."

"The issue that’s driving the whole theme are cost, quality, access,

and in the back of everybody’s mind is the aging population,"

says Corman, who ran a similar program at Rider in the autumn of 1996,

at the height of the national healthcare debate. She noticed then

that there was an almost unanimous reverence of change. "What

we were discovering in 1996 was just how much things were changing,

how quickly they were changing and how much more important it is for

everybody in the industry to become actively involved with getting

information and keeping abreast of all the changes."

"Everybody pretty much agreed on what the issues were — cost,

quality, and access," says Corman. "But nobody’s denying that

the problems don’t exist. What people disagree on are the priorities."

Rider has made it a priority to provide career support for its hordes

of students already working in the pharmaceutical industry. Rider

offers a new healthcare concentration within its MBA program and a

new undergraduate minor in health administration.

Peter J. Mladineo

Top Of Page
Pharmaceutical

Opportunities

Here is yet another opportunity for students to get

on board New Jersey’s lucrative pharmaceutical career bandwagon: Study

pharmacy via the 2+4 Pre-Pharmacy Program, a joint venture between

the Rutgers University College of Pharmacy and the Camden College

of Arts and Sciences. Students admitted to the program in the fall,

1998, semester begin their course at Rutgers Camden. Upon completion

of first and second-year pharmacy curricular requirements, they are

guaranteed admittance into the doctor of pharmacy program at Rutgers

College of Pharmacy, on the Busch campus in Piscataway. This six-year

program yields the PharmD assignation, the only degree now given by

the College of Pharmacy.

Applications for the program are still being accepted; the program

will accept 20 to 25 students. Call 732-932-4436.

Top Of Page
Attracting the Media Glare

For anyone who ever wants national press coverage

on any topic, the lineup at this "meet the press" breakfast

at the Hyatt was impressive — reporters and editors from the three

biggest news providers worldwide: Associated Press, Bloomberg News,

and Dow Jones News Service.

Those who came to the March 11 breakfast, sponsored by the Biotechnology

Council of New Jersey, thought they were going to learn how to place

pharmaceutical and biotech stories. They did, but they also got a

fascinating peek into the intricate world of global media, and the

tips they received can serve as a PR primer.

The overall message from all three news services was — when in

doubt, call. When in doubt, ask. "We are constantly looking for

ideas," says Darrell Delamaide of Bloomberg Financial Services.

"Journalists are in the business of telling stories. We welcome

phone calls pitching a story."

The AP and Dow Jones reporters are particularly interested in trend

stories, while Dow Jones and Bloomberg focus mainly on publicly held

companies.

Minutes count with rolling deadlines. AP’s first deadline is at 10:25

a.m., and the story can get longer as the day goes on. Similarly,

Bloomberg prints some version of a big story right away then adds

to it and edits it for the rest of the day, and by the end of the

day it is supposed to be finished or "camera ready."

Those cameras, nevertheless, belong to other newspapers, since Bloomberg

has no daily print paper of its own. "Our ambition is to be an

electronic newspaper with the type of report you would find in the

New York Times or the Wall Street Journal. This seems to be the medium

for the 21st century," says Bloomberg’s Delamaide.

Delamaide returned last fall to the United States after 20 years overseas

(10 in Paris, 10 in Frankfurt), where he had covered international

banking and finance for AP-Dow Jones, Institutional Investor, the

International Herald Tribune, and Bloomberg. An alumnus of St. Louis

University, Class of 1971, he has a master’s degree in international

affairs for Columbia, and is married to a German-born journalist,

Veronika Hass.

The corporate part of Bloomberg’s health care reporting is handled

from Princeton, but financial markets are covered by the New York

office, and the Washington, D.C., office would do the government and

economic angles.

Bloomberg downloads audio clips to its "Bloomie" terminals

so a speech by Alan Greenspan or a pharmaceutical CEO can be heard

complete, with all the inflections and innuendo, without the editing

and interpretation that any print version would give. Not being live

has an advantage: You can call up the digital archive at any time.

Most press releases arrive electronically from one of the two major

PR wire services, PR Newswire or Business Wire. "Calls are the

most effective way to find out if there’s any interest, and that can

be followed up by the fax," says Delamaide. If you don’t call,

half the day may go by before your fax reaches the right desk. "Our

feeling is, by now, that the fax is too slow for us. We have a whole

desk of people monitoring the wire minute by minute."

Jennifer Fron Mauer, based in Jersey City, has a master’s degree

from Columbia and five years experience with Dow Jones, most recently

as the transportation reporter.

Unless you plan on giving Mauer an exclusive, don’t expect Dow Jones News Service

to honor your press release’s request to print a story

on the date you choose. Such a request, called an "embargo,"

can cause all kinds of journalistic mayhem. "We do not accept

or honor embargoed press releases," she says.

In contrast, AP does work with embargoes. "PR people let me know

about something weeks in advance," says Linda A. Johnson,

the science and medicine reporter at the Associated Press in Trenton.

In fact, if you want your story to get good AP coverage, schedule

the press conference at a time convenient for Johnson. If your firm

has a division in another city, include that in your press release

so AP can alert that city’s paper.

Along with a release send a complete press kit with company information,

including officers, owners, short-term and long-term research goals,

subsidiaries, products on the market, and home phone numbers for a

PR person. AP needs negatives or digital photos. No print photos.

"I like to see every release, and I keep voluminous files, but

we are writing for the general public and I am looking for the bigger

stories," says Johnson. Don’t expect her to write about routine

management or board changes, or early clinical trial results, or a

small company’s earning statements. Do call her about final FDA approvals

and give a couple of days notice on research to appear in a major

scientific publication, to give her time to assemble expert opinion.

"Pick and choose something really good," says Johnson, "and

tell me in advance so I can get it up early in the day."

Success in placing a story is not just luck, it’s know how. The trio

agreed on these tips:

Be clear. Mauer warns that Dow Jones’ Jersey City news

desk has 50 people processing faxes and writing short (three paragraph)

news stories. These reporters are probably just out of college and

do not have medical backgrounds, so don’t depend on jargon or acronyms.

Be there, says Mauer. Don’t issue a press release when

your public relations person is about to go on vacation. Provide night

numbers. To protect against your competitor sending a false fax, Dow

Jones must verbally confirm every fax it receives, so if your contact

person is not available, it won’t run. And AP’s Johnson warns, "If

you put out a release at 9 a.m. and the medical officer is not available

until 3 p.m., I might pass on it all together."

Don’t bury bad news at the bottom of the press release.

"We see ourselves as agents of the shareholders," says Delamaide.

"Our job is not to put your story across. The goals aren’t

necessarily always the same."

Know what you are talking about. "I can tell when

somebody is reading off a piece of paper and doesn’t know the subject,"

says Mauer. Your information will be up on the wire, so don’t guess

about answers you don’t know. Be correct or say you will call back.

Be prepared. Have basic and background information ready

so you can fax it right away when a reporter calls, says Johnson.

Be ready with quotes, think of analogies in advance, and also think

ahead about the ramifications of your announcement. What will it mean

to your Aunt Tessie?

Send your less important stories to the right place: For

the AP, fax to the Daybook (see below). For Dow Jones, fax to Spot

News. For Bloomberg, a PR news service is preferable to a fax.

Give advance notice of your big story. "If FDA will

make an announcement next week, talk to me now," says Mauer, "so

I’ll be able to write about it with some intelligence."

Leave short voice mail messages. "Anything longer

than a half-minute, I delete," says Delamaide.

John McWilliams of PR Newswire (212-596-1500; fax, 800-793-9313)

introduced the speakers:

Bloomberg Financial Markets, 100 Business Park Drive,

Box 888, Princeton 08542-0888, news phone 609-279-4000; fax, 609-497-6577.

Darrell Delamaide, editor, extension 4071, E-mail ddelamai@bloomberg.com">>ddelamai@bloomberg.com .

Don’t call after 4 p.m., and his least busy time is from 11 a.m. to

1 p.m.

Kerry Dooley (extension 4016) is responsible for drugs and biotech,

and Marion Gammill (extension 4097) does health care and medical

devices. From the District of Columbia Kristin Reed and Kristin

Jensen (yes, the same first names) cover the Food and Drug Administration

(202-624-1820) and Paul Heldman reports on Medicare and health

policy. From California Jim Finkle 415-912-2960 writes about

biotech and health care and occasionally contributes to the "Taking

Stock" column.

Associated Press, 50 West State Street, Trenton 08608,

609-392-3622; fax, 609-392-3525. Send one fax to the AP Daybook and

a second copy to Linda A. Johnson, the science and medicine

reporter.

John Hendren in New York works on the financial aspects of pharmaceuticals

(mergers and acquisitions) and Lauran Neergaard (202-776-9467)

covers FDA issues from D.C. Fax first, then call from 10 a.m. to 7:30

p.m.

Dow Jones News Service, Dow Jones & Co., Harborside Financial

Center, 600 Plaza Two, Jersey City 07311-3992. Pete Rooney, news

editor for spot news, 201-938-5161; fax, 201-938-5600. Jennifer

Fron Mauer (pharmaceutical and biotechnology) 201-938-5287 and

Louis Hau (medical devices and HMOs) 201-938-5240; fax for both,

201-938-5060. FDA matters, Otesa Middleton in Washington, 202-8622-6654;

fax, 202-223-8039. The best time to call is after 4 p.m.

Barbara Fox

Top Of Page
Art Smarts

What can you expect from an art director that you wouldn’t

expect from an artist? For one thing, says Russell Carley, recently

appointed art director for Stonehouse Media, the art director will

try to please you as much as himself.

And despite his years spent trying to please a canvas, Carley has

developed acute sensitivities for pleasing customers. "A big thrust

of art direction is that you not only want to please the client, but

you want to make sure that the client has a good product," he

says. "We take it upon ourselves not only to please the client

but to stand behind our work. That’s a very important thing, too,

in terms of art direction."

Carley is a panelist at the Moving Image Professionals meeting, "The

Art of Art Direction" on Wednesday, March 25, 6:30 p.m. at the

Palmer Inn. The other panelists are Gary Radin, a production

designer for Acme Industrial, and Beverly Littlewood, a freelance

art director. The moderator is Tracy Anderson. Call 609-716-1737.

Carley lived out the artist’s dream in his youth; living poor and

painting during his 20s and 30s from a loft on the edge of Little

Italy. For a time he lived above a young unknown actress named Jessica

Lange, and Carley says that for those 18 years in Manhattan he

accumulated stories "enough for three men and a small boy."

In the early ’80s he switched his profession to the more lucrative

graphics and television industry. His first corporate job was for

ABC Television, which was "just at the beginning of the graphics

explosion." Since then he has been freelancing within the graphics

arena and for the last 10 years he has been living in Jersey City.

Stonehouse, which does website and CD-ROM work for Fortune 500 companies,

small production firms, and the government from its 4390 Route 1 headquarters,

hired him six weeks ago to expand its graphics and animations capabilities.

"Art direction can serve many functions," he says, "but

we bring the same set of standards to bear on all of it."

"The object is for both sides to make sure we’re all on the same

page or wavelength. We want to know how to present this project. What

emotions, what feelings, what ambience. As an art director, I deal

with graphics, image, and animation. I would want to make my graphics

conform to that idea, even choosing a font."

Bearing in mind the emotional links between human beings and art,

it’s also necessary to "try to circumvent unreasonable prejudices,"

Carley says. "What you want to do as an art director is keep in

mind the end result and use whatever means is at hand to produce an

end result. It’s really the end result that counts, not the means.

If it works with different colors, then it works. There’s always dialogue

with people in trying to resolve these issues."

As Carley notes, art direction smacks a little of the Rembrandt school.

"In art direction, you’re not producing, you’re just directing,"

he says. "How are you going to invent, not what are you going

to invent. To get that tone that’s necessary, where it’s light or

fast and breezy, or slow and lyric. Everyone has to know what the

purpose of this product is going to be."

When we ask whether he fit the stereotypical image of the pony-tailed

art director, Carley, 58, surprises us: no ponytail. "I guess

art directors come in all shapes and sizes," he says. "I probably

look more like a banker than an art director."

The transition from the Bohemian artist’s life in Manhattan to a graphic

design expert commuting 160 minutes per day from Jersey City is not

taxed with bitterness. "I may have done some things I wish I hadn’t

done but I can honestly say that I did all of the things that I wanted

to do." It must be a good commute.

Peter J. Mladineo

Top Of Page
Acing the Angel

Investment

Trying to find a venture capitalist for a small start-up

is about as tough as finding a Beltway insider who doesn’t want a

book deal. So the small start-up must find the angel investor instead.

Of course, finding the angel investor is similarly snaggy.

But now small companies seeking up to $1 million in equity capital

can now have their escort to the angels. It’s called ACE-Net, an Internet-based

system that lists the profiles and prospectuses of companies seeking

capital for accredited investors to peruse. The service is developed

by the U.S. Small Business Administration’s office of advocacy. On

a state level it’s being administered by NJIT’s Enterprise Development

Center. The information will be stored on a database at NJIT.

The system is password-secured and costs $450 for the companies and

the angel investors to join. Companies asking for less than $1 million

will be eligible to use the short form, which is being adopted by

the securities regulators in 15 states. New Jersey is not one of them

yet, but it will be implemented in this state shortly, says Lou

Gaburo, assistant director of the NJIT Enterprise Development Center.

A kickoff meeting at NJIT is being planned for Thursday, April 30,

although no details have been set. The system is expected to be operational

in May or June, Gaburo adds.

ACE-Net is one of many programs to be discussed at the New Jersey

Entrepreneurial Network’s meeting on leveraging New Jersey resources

on Wednesday, April 1, at noon at the Forrestal. Call 609-279-0010.

Stash Lisowski, the director of the NJIT Enterprise Development

Center, will provide the ACE-Net discussion.

The meeting is cosponsored by the Technology Help Desk and Incubator

of the NJSBDC, U.S. 1 Newspaper, and Business News New Jersey, and

features a panel with Gail Eagle of Gail Eagle Custom Publishing

Associates, a home-based business at 3 Rosemary Road in East Brunswick,

and Henry Wojtunik, president of Anacom Systems, a developer

of fiber optic equipment in the 100 Jersey Avenue incubator in New

Brunswick. Anacom recently received a $1 million order from a Korean

telecom manufacturer and is in the midst of a sizable expansion, says

Wojtunik.

Nearly 20 other organizations that help small business are sending

representatives to the meeting. These include the Mercer County College

Small Business Development Center plus the SBDC’s procurement and

international trade programs, the MIT Enterprise Forum, the New Jersey

Economic Development Authority, the New Jersey Technology Council,

New Jersey Institute for Technology’s Enterprise Development Center,

Princeton University’s Center for Photonics and Optoelectronic Materials,

the Rothman Institute of Entrepreneurial Studies, the Princeton Plasma

Physics Laboratory, the Stevens Technology Ventures Business Incubator,

and the United States SBA Loan Guarantee Program, represented by Prestige

State Bank.

Attendees will also get a guide profiling 35 different business development

programs.

Top Of Page
Trading Up

Get a crash course in international trade at the Princeton

Chamber’s TradeWorld ’98, "Global Trading for 2000 and Beyond,"

a forum and exposition set for Monday, April 6, from 8 a.m. to 6 p.m.

at the Marriott. The event features Gualberto Medina, state

commerce commissioner; Stephen Kukan of Prosperity New Jersey;

and John Clancy, of Sea-Land Service Inc. The cost is $125 (including

breakfast, lunch, and reception), and you can display materials from

your company for an additional $125; booths cost $400. Call 609-520-1776.

Medina opens the forum at 8:40 a.m., Kukan speaks at 12:15 p.m., and

Clancy speaks at the 4:15 p.m. reception along with John Wiegand

of Screen Printing USA.

Carlos Kearns, director of the state Division of International

Trade, will chair a 9 a.m. panel with trade representatives, including

Sergio Hidalgo, trade commissioner of the Mexican Foreign Trade

Commission, Michael Baume, consul general of Australia; and

the deputy consul and trade commissioner of Canada. Other countries

to be represented are Belgium, Argentina, Indonesia, Switzerland,

Hungary, and Chile.

Concurrent 10:30 a.m. sessions include one on trading and distribution

with Laurence Harper of Ballentrae International, Jonathan

Plimpton of International Business Management, and Steven Richman

of Gallagher Briody & Butler as moderator (Richman chairs the committee

for this event). Robert Riley of Ward Associates moderates a

logistics and transportation panel "In/Out/And on Time"

that includes Bonnie Rainey-Wright, of Airgroup Express and

a representative of Unz & Company.

Hidalgo, Paul Holland, vice president of PNC Bank; and Robert

Crook, vice president of CoreStates Bank will give a 1:45 p.m.

seminar to "demystify international banking for the American business

community." Concurrently Takako Lento of InterComm Inc.

moderates "Team Building — How to Deal Effectively with People

of Different Nations," with John Bing, president of ITAP

International, and Stephen Smith of Novartis Pharmaceutical

Corp.

At 3 p.m., Gregory Chow, Princeton University economics professor;

Henry Raimondo, a Rutgers professor at the Eagleton Institute,

and Ingrid Reed, director of Eagleton Institute, will discuss

the implications of overseas economic conditions.

Also at that time is "Making the Marriage Work, a workshop on

joint ventures and partnering, moderated by Dorothy Carmalis,

recently retired from the state division of international trade, including

Mario Brossi of Switzerland, Donald Marsan of Canada,

and Edward Burton, deputy director of the state’s international

trade division.

Top Of Page
Searching Polish

If you had held the same job for 20 years, your job

search skills may be rusty. Job seekers can sign up for free week-long

workshops sponsored by the Jewish Family & Children’s Service of Greater

Mercer County.

Ten people in managerial, technical, or professional fields can attend

these workshops taught by specialists from the New Jersey Department

of Labor at the JFCS conference wing, 707 Alexander Road, Suite 102.

The program is open to the public and is free (thanks to a grant from

the United Way of Greater Mercer County) but preregistration is required.

To register call John F. O’Halloran Jr. at 609-987-8100.

The program runs Monday to Friday, March 30 to April 3, 8:30 a.m.

to 4 p.m. Spouses may join program participants at presentations on

Friday that deal with consumer credit counseling.

Top Of Page
Long Line Learning

Two years ago, when "distance learning" was

still fairly new, Peterson’s Guide published its first Guide to Distance

Learning. Also two years ago in March, Jennifer Guy started

her MBA via computer from the University of Phoenix (U.S. 1, July

31, 1996).

Guy is now just finishing her last course to complete her degree,

and Peterson’s has just come out with its second Guide to Distance

Learning ($26.95). At the time Guy wrote her article, her mother opposed

her choice, but this learning mode has gained much wider acceptance

now. In fact, so many colleges have joined the distance learning parade

that the latest edition, at 636 pages, is considerably fatter than

the first.

Guy’s article compared Phoenix with New Jersey’s distance pioneer,

Thomas Edison State College. The current Peterson’s lists programs

from nine of New Jersey’s community colleges plus such four-year institutions

as Caldwell, Fairleigh Dickinson, New Jersey Institute of Technology,

St. Peter’s, Seton Hall, and Stevens Institute of Technology. It lists

more than 800 institutions offering 237 associate degrees, 285 baccalaureate

degrees, 442 master’s, 33 doctoral programs, plus undergraduate and

graduate certificate programs.

Along with tips on how to find study and find the right program, the

guide is enlivened by thumbnail sketches of students and their experiences.

About 80 colleges chose to participate (one assumes they paid for

it) in a special section with extended descriptions. To complement

the guide Peterson’s will launch an online database at http://www.LifeLongLearning.com.

"It’s been a long road, but to be able to work whenever I want

has definitely made a big difference," says Guy. "And my mother

no longer thinks I am getting my degree on a matchbook."

Corrections or additions?


This page is published by PrincetonInfo.com

— the web site for U.S. 1 Newspaper in Princeton, New Jersey.

Facebook Comments